Latest Content

Cancer Therapy at End of Life May Not Boost Survival

June 17th 2024, 9:00pm

By Brielle Benyon

Article

Patients who received systemic therapy at the end of life did not have longer overall survival averages than those who did not receive therapy at end of life.

FDA Approves Keytruda Plus Chemo for Advanced Endometrial Cancer

June 17th 2024, 5:13pm

By Brielle Benyon

Article

The Food and Drug Administration approved Keytruda plus chemotherapy, followed by single-agent Keytruda for primary advanced or recurrent endometrial cancer.

Allowing Your Heart to Break as a Cancer Survivor

June 17th 2024, 5:00pm

By Joe Bullock

Article

Experiencing losing a friend to cancer in the cancer community is never easy, but it’s OK to allow your heart to break.

Multiple Myeloma Progression Still Slowed With Reduced Tecvayli Dosing

June 17th 2024, 3:00pm

By Alex Biese

Article

Data show that patients’ multiple myeloma still fails to progress if patients receive less-frequent Tecvayli.

FDA-Approved Rytelo a ‘Game Changer’ for Some Patients with MDS

June 17th 2024, 1:00pm

By Alex Biese

Article

Approximately half of the patients with MDS who responded to treatment with Rytelo went a year without needing a blood transfusion, one expert explained.

Moving the Needle With Disparities in Multiple Myeloma

June 16th 2024, 6:00pm

By Darlene Dobkowski, MA

Article

Increased awareness and support may be one of the many ways to help decrease the impact of disparities in multiple myeloma.

What I Wish Medical School Had Taught Me About Cancer

June 15th 2024, 6:00pm

By Wendy Harpham

Article

Medical school didn't teach me how to help patients find hope during tough times.

Don’t Delay Bringing Up CML Concerns, a Doctor Says

June 15th 2024, 2:00pm

By Brielle Benyon

Video

To ensure best outcomes, patients with chronic myeloid leukemia should maintain frequent communication with their care teams — even between appointments.

Innovation and Resilience in the Genitourinary Cancer Space

June 15th 2024, 2:00pm

By Mike Hennessy Jr.

Article

Within the genitourinary cancer space, there have been many treatment advances over the past year.

Most Patients With CML Can Continue Their Normal Lifestyle During Treatment

June 14th 2024, 10:00pm

By Brielle Benyon

Video

Most — though not all — side effects from chronic myeloid leukemia treatment improve over time, an expert said.

FDA Approves Blincyto for Adults, Children with Acute Lymphoblastic Leukemia Subtype

June 14th 2024, 9:20pm

By Brielle Benyon

Article

The FDA approved Blincyto for patients aged one month and older with CD19-positive, Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.

Organizations Can Help Patients with CML Face the ‘Long Treatment Journey’

June 14th 2024, 9:00pm

By Brielle Benyon

Video

A chronic myeloid leukemia diagnosis can negatively affect patients and their loved ones’ mental health, but there are resources that can help.

FDA Approves Imfinzi Plus Chemo for dMMR Endometrial Cancer

June 14th 2024, 8:44pm

By Brielle Benyon

Article

The FDA approved Imfinzi plus carboplatin and paclitaxel followed by Imfinzi alone in patients with primary advanced or recurrent dMMR endometrial cancer.

Bispecific Antibodies Get ‘Fantastic’ Responses in Pretreated Myeloma

June 14th 2024, 7:00pm

By Alex Biese

Article

As part of the CURE® Educated Patient® Summit, one expert reviewed the landscape of bispecific antibodies, such as Tecvayli, for multiple myeloma.

How Do I Love Myself Right Here, Right Now After Cancer?

June 14th 2024, 5:00pm

By Bonnie Annis

Article

After having breast cancer, I worked on learning to accept and love myself.